Eurepa-V 0.5/0.2 Tablet is used to manage Type 2 Diabetes Mellitus in adults when diet and exercise alone, or monotherapy, fail to control blood sugar levels adequately. This combination antidiabetic medicine integrates a meglitinide (Repaglinide), which stimulates rapid, short-burst insulin release, with an alpha-glucosidase inhibitor (Voglibose), which delays the digestion and absorption of carbohydrates from the gut. This dual action targets blood sugar spikes after meals.
58% CHEAPER

Prevego Healthcare & Research Pvt.ltd.
Strip of 10 Units
₹67.07
₹6.71/Units





































































